NATALIE AMASON: Open Payments
NPI 1083015689 · CENTRALIA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$751 in 47 payments from 12 companies in 2025. Trend: 2023 $1,092 · 2024 $731 · 2025 $751
Food & beverage: $751
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $170 |
| UCB, Inc. | 5 | $100 |
| Incyte Corporation | 4 | $86 |
| Novartis Pharmaceuticals Corporation | 4 | $83 |
| Organon LLC | 10 | $78 |
| Amgen Inc. | 3 | $54 |
| Galderma Laboratories, L.P. | 3 | $48 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $36 |
| Almirall LLC | 2 | $35 |
| Janssen Biotech, Inc. | 1 | $22 |
Products named: SKYRIZI, Bimzelx, OPZELURA, COSENTYX, OTEZLA, NEMLUVIO, VTAMA, RINVOQ.
Industry payments across IL — which companies pay providers there.
